|
Final report Living clinical practice guidelines for management of ...
otator cuff disorders: a systematic review of clinical practice guidel riority clinical questions for the A tralian living guidelines for the management of Juvenile Idiopathic Arthritis. Pediatric Rheumatology 2 Jones J and Hunter D. Qualitative research: consensus methods for medical and health services research. Bmj 1995; 311: 376-380.
Rees - Arthritis Australia
With self-management for chronic illness increasingly being seen as an important component of primary care, evidence from controlled clinical trials suggests that self-management programs are more effective than information-only patient education in improving clinical outcomes (Arthritis and Osteoporosis Victoria [AOV] 2015).
Outdated ‘old age’ views of arthritis risk a painful and costly future ...
Reset RA is developing world-first immunotherapy aiming to cure rheumatoid arthritis, which is a chronic condition affecting over half a million Australians. With MRFF funding, Reset RA is tracking towards its planned clinical trials in 2026, but many other projects still have unrealised potential.
Scientific summary: ARA Ken Muirden Overseas ... - Arthritis Australia
The support of Arthritis Australia and the Ken Muirden ARA Fellowship has equipped me with a broad spectrum of research and clinical experiences which I look forward to bringing home, to benefit Australians with rheumatic conditions.
Arthritis Australia 2026 Budget Submission
Investing $5m over 5 years into innovative approaches such as adaptive platform clinical trials in each of the most common arthritis conditions could be a game changer, with further investment for those progressing to new treatments.
PATIENT INFORMATION ON ANIFROLUMAB Brand name: Saphnelo
• Infusion-related reaction • Bronchitis • Herpes zoster (7.2%) Clinical trials showed that all cases of herpes zoster presented as skin manifestations and resolved without discontinuation of anifrolumab. Less common or rare possible side effects: The serious side effects with anifrolumab include: • Pneumonia which can lead to death
Evaluation of Preferred Investment Models for Arthritis and ...
Research We are the leading non-government funder of arthritis research in Australia and work in partnership with the university and medical sector to support and advocate for increased funding for research into arthritis and musculoskeletal conditions.
National Strategic Action Plan for Arthritis
The establishment of the Australia and New Zealand Musculoskeletal Clinical Trials Network (ANZMUSC), which aims to improve clinical research quality and capacity.
Hyaluronic acid — Arthritis Australia
A 2022 review of the clinical trials of hyaluronic acid demonstrated that hyaluronic acid injections may lead to a small reduction in knee osteoarthritis pain. However, this reduction in pain was not considered clinically important.
19562 Arth Aust Arthritis&Exercise paper update
Objective Both in Australia and worldwide, osteoarthritis and rheumatoid arthritis are major causes of disability and chronic pain. Research has established exercise as a safe and recommended treatment for these arthritides. Despite evidence and clinical guidelines, both consumers and health practitioners report confusion and uncertainty around the prescription of, and participation in, exercise.
|
